212 results on '"Catarina, Xavier"'
Search Results
2. Tradutores audiovisuais e o tabu: um estudo de atitudes relativas à tradução para legendagem na televisão portuguesa
- Author
-
Catarina Xavier
- Subjects
Estudos de Tradução ,Atitudes ,Portugal ,Televisão ,Estratégias de tradução ,Translating and interpreting ,P306-310 - Abstract
No âmbito dos Estudos da Tradução Audiovisual, vários estudos têm sido dedicados à investigação da tradução da linguagem tabu, na área da dobragem, da legendagem, o fansubbing, e mais recentemente até na área da Acessibilidade. Contudo, esta investigação tem se visto restrita à análise de textos, sendo mais escassa à investigação do agente humano no processo da tradução. Neste enquadramento, este estudo empírico tem por objetivo investigar as atitudes de tradutores audiovisuais relativamente à tradução para legendagem na televisão de sinal aberto em Portugal. Aplicou-se, com esse fim, um questionário a tradutores. Os resultados demostraram um alto nível de concordância com a manutenção do tabu, tal como a relevância de diferentes aspectos relacionados com o papel que o tabu assume nas narrativas fílmicas. Não obstante, estas atitudes diferem da estratégia mais comum na tradução e legendagem de tabu no contexto português, a omissão, o que pode indiciar um novo paradigma na tradução de linguagem tabu.
- Published
- 2024
- Full Text
- View/download PDF
3. Swearing in the Movies: Intratextual and Extratextual Functions of Taboo
- Author
-
Catarina Xavier
- Subjects
taboo language ,films ,functions of taboo ,characterisation ,Language and Literature - Abstract
Audiovisual media reflect language use in the community and the context of attitudes and stereotypes regarding different language varieties. Against this backdrop, taboo language has become a frequent resource for linguistic characterisation in cinema. Studies related to taboo language in audiovisual contexts suggest some functions of these words in films, though not systematically nor layered. Based on the work of Allan and Burridge (“Swearing”) on the functions of taboo language in its authentic use and Delabastita (“Great Feast of Languages”) on the extratextual functions of multilingualism in Shakespearean work, this article offers an empirical, multidisciplinary, systematic approach to the use of taboo language in films. We propose a typology of four intratextual and three extratextual functions of taboo language in audiovisual contexts. This typology will then be tested on a corpus of films via a detailed multimodal quantitative and qualitative analysis.
- Published
- 2024
- Full Text
- View/download PDF
4. Atuação farmacêutica em atividades de ensaios clínicos desenvolvidos em um hospital universitário em Salvador Bahia
- Author
-
Milena da Silva Lima, Catarina Xavier Fernandes, Alline Mikaele Nunes Wildemberg Brauer, Daiane Gondim, and Leonardo Kister
- Subjects
Pharmacy and materia medica ,RS1-441 ,Pharmaceutical industry ,HD9665-9675 - Abstract
Introdução: As atribuições do farmacêutico na execução de atividades de ensaios clínicos envolvem o processo de gerenciamentos dos produtos sob investigação. Dessa forma, caracterizam-se as responsabilidades pelo recebimento, armazenamento e controle desses produtos e por todo o suporte ao delineamento da pesquisa, junto aos demais profissionais da equipe designada para o estudo. Adicionalmente, estão inseridos as atividades de dispensação dos produtos sob investigação e o preparo, bem como acompanhamento da adesão terapêutica do participante, possíveis reações adversas ao tratamento proposto, orientações sobre o tratamento e realização das comunicações periódicas das atividades farmacêuticas executadas com os monitores, patrocinadores e investigadores dos estudos em curso. A atuação do farmacêutico nas atividades de ensaios clínicos é de extrema importância para uma condução dos protocolos de pesquisa e contribui para minimizar eventos adversos e desvios de delineamento dos estudos. O impacto da atuação dos farmacêuticos é ainda pouco conhecido. Objetivo: Caracterizar as atividades desenvolvidas pelo farmacêutico em um hospital universitário no primeiro semestre de 2022. Metodologia: Estudo descritivo, retrospectivo, de levantamento histórico das atividades desenvolvidas pela equipe de farmacêuticos do serviço de ensaios clínicos do Setor de Farmácia Hospitalar de um hospital universitário em Salvador-Bahia no primeiro semestre de 2022. Os dados foram contabilizados e aplicada estatística descritiva. Resultados e Discussão. No período avaliado houve doze estudos ativos no centro de pesquisa, sendo que seis tiveram atuação dos farmacêuticos, inseridos nas especialidades de infectologia, imunologia, cardiologia e gastro-hepatologia. Esses protocolos envolveram o atendimento de 120 participantes, com 123 dispensações ambulatoriais de medicamentos. Foram realizadas 06 solicitações e 08 recebimentos de medicamentos no período avaliado. Foram identificadas 02 devoluções de medicamentos para patrocinador e 04 destruições de medicamentos no próprio centro. A comunicação efetiva com patrocinadores para alinhamento e orientações sobre os protocolos clínicos ocorreu em 09 monitorias remotas e 07 monitorias presenciais. Conclusão: A pesquisa clínica é uma atividade multiprofissional e transdisciplinar, que envolve conhecimentos e habilidades específicas dos profissionais, além do trabalho compartilhado em equipe. O farmacêutico é um profissional indispensável na gestão racional dos produtos sob investigação nos ensaios clínicos e suas atividades contribuem para a adequada segurança na condução de estudos em pesquisa clínica.
- Published
- 2023
- Full Text
- View/download PDF
5. Vismodegib for treatment of periocular basal cell carcinoma – 6-year experience from a tertiary cancer center
- Author
-
Catarina Xavier, Edgar Lopes, Catarina Bexiga, Cecília Moura, Emanuel Gouveia, and Ana Filipa Duarte
- Subjects
Hedgehog proteins ,Skin neoplasms ,Carcinoma, basal cell ,Dermatology ,RL1-803 - Abstract
Abstract Background: The treatment of advanced periocular basal cell carcinomas becomes a challenge as surgery may involve highly mutilating procedures. Vismodegib is the first selective hedgehog inhibitor approved for the treatment of locally advanced tumors or metastatic disease. Objective: Analyze the results of treatment with vismodegib for advanced periocular basal cell carcinomas in a real-life setting of a reference center between 2014 and 2020. Methods: Retrospective longitudinal study. The patient’s demographic profile, comorbidities, tumor characteristics, and treatment outcomes were analyzed. Results: A total of 13 patients were included. Median follow-up and treatment duration were 15.9 and 10.5 months, respectively. Objective clinical response rate was 76.9%: 30.8% had a complete response and 46.2% a partial response. The median duration of response was 13 months. Progressive disease was observed in 38.5% of cases, with a median of 19 months after the beginning of treatment. Eighty-four percent of the patients had at least one adverse event, and 61.54% needed to interrupt treatment temporarily or permanently to increase tolerability. Study limitations: Being a retrospective study in a real-life setting, the evaluation of objective clinical response was subjective to physician appreciation. Conclusion: Vismodegib is a safe and effective treatment for locally advanced basal cell carcinoma. To prevent recurrences, the drug should be used continually when tolerated. The role of neoadjuvant vismodegib before surgery is being investigated and might add an important step in searching for a definitive treatment for these cases.
- Published
- 2022
- Full Text
- View/download PDF
6. Avaliação e qualificação de fornecedores de medicamentos no Hospital Universitário Dr. Washington Antonio de Barros em Petrolina-PE
- Author
-
Catarina Xavier Fernandes, Hirlla Karla de Amorim, Izabella Maria Pereira Virginio Gomes, and Marcelo de Maio Nascimento
- Subjects
Pharmacy and materia medica ,RS1-441 ,Pharmaceutical industry ,HD9665-9675 - Abstract
Introdução: A gestão de materiais e suprimentos possui papel estratégico no contexto da modernização da Farmácia Hospitalar. Diante disso, a gestão da aquisição de medicamentos se afigura como uma importante área de investigação, uma vez que instituições públicas destinam grande volume de recursos financeiros à aquisição desses produtos. Método: O presente estudo teve por fim avaliar o desempenho de fornecedores de medicamentos do Hospital Universitário Dr. Washington Antônio de Barros (HU/UNIVASF), localizado na cidade de Petrolina-PE, segundo os critérios de aceitação estabelecidos no edital do Pregão 30/2015. Trata-se de um estudo transversal de caráter descritivo e prospectivo, realizado entre os meses de dezembro de 2015 a março de 2016. O instrumento utilizado à coleta dos dados foi o “Formulário-Avaliação e Qualificação de Fornecedores”, com avaliação dicotômica, sim ou não, utilizado pelo Setor de Farmácia do HU/UNIVASF. O instrumento possui nove itens: nota fiscal, quantidade de medicamentos entregues, marca, especificação, embalagem, rotulagem, prazo de entrega, validade e horário de entrega. Os dados foram analisados por meio do programa EXCELL-2013. Resultados E Discussão: Entre os 16 fornecedores homologados no Pregão 30/2015, apenas 14 foram avaliados no período do estudo: 21% (03) Indústria Farmacêutica (IF), 79% (11) Distribuidoras de Medicamentos (DM). Observou-se que nenhum fornecedor cumpriu os nove itens, entretanto IF apresentou o melhor desempenho com 77,77% de critérios atendidos. Com relação ao item Prazo de Entrega, 5/11 empresas do grupo DM cumpriram com os critérios estabelecidos, enquanto no grupo IF, apenas 1/3 empresas conseguiram atender as exigências do Edital. No item Validade foi observado o cumprimento dos critérios por 3/11 do grupo DM e 2/3 do grupo IF. Por conseguinte, a análise dos dados demonstrou que ambos fornecedores obtiveram aproveitamento de 100% nos itens Nota Fiscal, Marca, Especificação, Embalagem e Rotulagem. Conclusão: Os resultados do presente estudo demonstraram que existiram, junto ao pregão 30/2015, descumprimentos no período de dezembro de 2015 a março de 2016 pelas empresas fornecedoras de medicamentos. Maior evidência foi observada no item Prazo de Entrega, o que é crucial para o serviço de farmácia, visto que gera o desabastecimento de medicamentos no hospital. Na comparação, entre os tipos de fornecedores as IFs se mostraram melhor qualificadas. Espera-se que os resultados da presente investigação possam estimular e fundamentar outros profissionais do HU-UNIVASF à realização de estudos futuros nas áreas da farmácia hospitalar e gestão de compras.
- Published
- 2023
- Full Text
- View/download PDF
7. A linguagem tabu em contexto: um estudo exploratório da linguagem tabu do ponto de vista das variáveis do registro
- Author
-
Catarina Xavier
- Subjects
linguagem tabu ,linguística sistémico-funcional ,uso marcado e não marcado ,Philology. Linguistics ,P1-1091 - Abstract
RESUMO Os falantes interagem através dos recursos linguísticos ao seu dispor para produzir significados ao nível da compreensão do mundo que os rodeia e dos restantes falantes (EGGINS, [1994] 2004, p. 11). O falante conhece, então, um código para cada situação comunicativa e adequa as suas seleções estilísticas ao contexto em que as produz. Neste enquadramento, este artigo exploratório investiga a linguagem tabu do ponto de vista das variáveis do contexto situacional, como propostas por Halliday (1978, [1985] 2014). Segue, por um lado, uma abordagem teórica onde propõe o cruzamento das variáveis do registro com os conceitos de uso marcado e não marcado (HYMES, 1974); e, por outro, aplica esta proposta num corpus escolhido para o efeito. Os resultados, de ordem quantitativa, demonstram o predomínio do uso não marcado da linguagem tabu no corpus.
- Published
- 2021
- Full Text
- View/download PDF
8. Immunogenicity Risk Profile of Nanobodies
- Author
-
Chloé Ackaert, Natalia Smiejkowska, Catarina Xavier, Yann G. J. Sterckx, Sofie Denies, Benoit Stijlemans, Yvon Elkrim, Nick Devoogdt, Vicky Caveliers, Tony Lahoutte, Serge Muyldermans, Karine Breckpot, and Marleen Keyaerts
- Subjects
nanobody ,immunogenicity ,anti drug antibodies ,dendritic cells ,T cell—DC interactions ,DC activation ,Immunologic diseases. Allergy ,RC581-607 - Abstract
Nanobodies (Nbs), the variable domains of camelid heavy chain-only antibodies, are a promising class of therapeutics or in vivo imaging reagents entering the clinic. They possess unique characteristics, including a minimal size, providing fast pharmacokinetics, high-target specificity, and an affinity in the (sub-)nanomolar range in conjunction with an easy selection and production, which allow them to outperform conventional antibodies for imaging and radiotherapeutic purposes. As for all protein theranostics, extended safety assessment and investigation of their possible immunogenicity in particular are required. In this study, we assessed the immunogenicity risk profile of two Nbs that are in phase II clinical trials: a first Nb against Human Epidermal growth factor Receptor 2 (HER2) for PET imaging of breast cancer and a second Nb with specificity to the Macrophage Mannose Receptor (MMR) for PET imaging of tumor-associated macrophages. For the anti-HER2 Nb, we show that only one out of 20 patients had a low amount of pre-existing anti-drug antibodies (ADAs), which only marginally increased 3 months after administering the Nb, and without negative effects of safety and pharmacokinetics. Further in vitro immunogenicity assessment assays showed that both non-humanized Nbs were taken up by human dendritic cells but exhibited no or only a marginal capacity to activate dendritic cells or to induce T cell proliferation. From our data, we conclude that monomeric Nbs present a low immunogenicity risk profile, which is encouraging for their future development toward potential clinical applications.One Sentence SummaryNanobodies, the recombinant single domain affinity reagents derived from heavy chain-only antibodies in camelids, are proven to possess a low immunogenicity risk profile, which will facilitate a growing number of Nanobodies to enter the clinic for therapeutic or in vivo diagnostic applications.
- Published
- 2021
- Full Text
- View/download PDF
9. Broadening the Applicability of a Custom Multi-Platform Panel of Microhaplotypes: Bio-Geographical Ancestry Inference and Expanded Reference Data
- Author
-
María de la Puente, Jorge Ruiz-Ramírez, Adrián Ambroa-Conde, Catarina Xavier, Jorge Amigo, María Ángeles Casares de Cal, Antonio Gómez-Tato, Ángel Carracedo, Walther Parson, Christopher Phillips, and María Victoria Lareu
- Subjects
microhaplotypes ,massively parallel sequencing ,bio-geographical ancestry ,mixed DNA ,human identification ,Genetics ,QH426-470 - Abstract
The development of microhaplotype (MH) panels for massively parallel sequencing (MPS) platforms is gaining increasing relevance for forensic analysis. Here, we expand the applicability of a 102 autosomal and 11 X-chromosome panel of MHs, previously validated with both MiSeq and Ion S5 MPS platforms and designed for identification purposes. We have broadened reference population data for identification purposes, including data from 240 HGDP-CEPH individuals of native populations from North Africa, the Middle East, Oceania and America. Using the enhanced population data, the panel was evaluated as a marker set for bio-geographical ancestry (BGA) inference, providing a clear differentiation of the five main continental groups of Africa, Europe, East Asia, Native America, and Oceania. An informative degree of differentiation was also achieved for the population variation encompassing North Africa, Middle East, Europe, South Asia, and East Asia. In addition, we explored the potential for individual BGA inference from simple mixed DNA, by simulation of mixed profiles followed by deconvolution of mixture components.
- Published
- 2020
- Full Text
- View/download PDF
10. Generation of fluorescently labeled tracers – which features influence the translational potential?
- Author
-
Fijs W. B. van Leeuwen, Bart Cornelissen, Federico Caobelli, Laura Evangelista, Latifa Rbah-Vidal, Silvana Del Vecchio, Catarina Xavier, Jacques Barbet, and Marion de Jong
- Subjects
Fluorescence ,Image guided surgery ,Molecular imaging ,Tracers ,Nuclear medicine ,Dual-modality ,Medical physics. Medical radiology. Nuclear medicine ,R895-920 ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Abstract Given the increasing exploration of fluorescent tracers in the field of nuclear medicine, a need has risen for practical development guidelines that can help improve the translation aspects of fluorescent tracers. This editorial discusses the does and don’ts in developing fluorescence tracers. It has been put forward by the European Association of Nuclear Medicine (EANM) Translational Molecular Imaging & Therapy committee and has been approved by the EANM board.
- Published
- 2017
- Full Text
- View/download PDF
11. A three-layered typology for the subtitling of taboo
- Author
-
Catarina Xavier
- Subjects
Linguistics and Language ,Communication ,Language and Linguistics - Abstract
The translation of taboo words has attracted scholars’ interest in studying it in the audiovisual context over the last decades. The surge of research on this predominant form of translation in everyday life has brought to light the communicative, pragmatic, and semiotic aspects as well as the technical constraints for subtitling taboo words. Previous research has primarily taken a quantitative method, discussed issues that justify their results, and suggested possible outcomes from a potential receiver’s point of view. While contributing to existing related literature, this paper argues that there is a need for a thorough, detailed examination of translation options in subtitling taboo words. The paper presents a three-layered typology of methods, strategies, and techniques, which provides a comprehensive description of audiovisual translators’ options. Following a bottom-up/top-down approach, the proposed typography is then put to the test in a corpus-based case study comprising six movies and their professional subtitles broadcast on Portuguese televisions.
- Published
- 2022
- Full Text
- View/download PDF
12. BEACHED SEA TURTLES ON THE COAST OF FORTALEZA, CEARÁ, BRAZIL, AND IMPLICATIONS FOR CONSERVATION OF THE TÁXON
- Author
-
Alice Frota Feitosa, Débora Melo Mendonça, Ícaro Ben Hur Moreira Pinto Menêzes, Ruama Catarina Xavier Rufino, Lidya Rosa Sousa Carvalho, Rodrigo Rabelo de Castro Sousa, Gabriel Chagas Lima, and Caroline Vieira Feitosa
- Subjects
General Medicine - Abstract
The Ceará’s state coast belongs to one of the most important areas of the South Atlantic for migration and feeding of sea turtles. Thus, the present study observed (1) which species occur in Fortaleza, (2) which species and sex are beached the most, (3) the life stage and (4) season that they most strand. We aimed to update existing information regarding the occurrence of sea turtles in Fortaleza, evaluate if seasonality influences beaching behavior, register the beached species on the coast of Fortaleza, and investigate the beaching behavior. This study was carried out in Fortaleza, Brazil. Data were obtained through monitoring and reports provided by the local community, from January/16 to December/19. A total of 112 beached turtles of four species were observed, and younger specimens were more observed. No significant differences appeared between the years, months, and the rainy/dry seasons on the number of the strandings. Females were observed more than males for all species, perhaps due to the use of the region as a migratory route for breeding and foraging. This is the first data for Ceará State published in a scientific paper, which can be used as the basis to raise awareness in the general population, and government, regarding the vulnerability of these organisms. Keywords: Chelonia mydas, juvenile turtles, female turtles, human activities, northeastern.
- Published
- 2022
- Full Text
- View/download PDF
13. Site-Specific Radiolabeling of a Human PD-L1 Nanobody via Maleimide–Cysteine Chemistry
- Author
-
Dora Mugoli Chigoho, Quentin Lecocq, Robin Maximilian Awad, Karine Breckpot, Nick Devoogdt, Marleen Keyaerts, Vicky Caveliers, Catarina Xavier, and Jessica Bridoux
- Subjects
cancer ,nanobodies ,PD-L1 ,site-specific ,PET ,gallium-68 ,Medicine ,Pharmacy and materia medica ,RS1-441 - Abstract
Immune checkpoint inhibitors targeting the programmed cell death-1 (PD-1) and its ligand PD-L1 have proven to be efficient cancer therapies in a subset of patients. From all the patients with various cancer types, only 20% have a positive response. Being able to distinguish patients that do express PD-1/PD-L1 from patients that do not allows patients to benefit from a more personalized and efficient treatment of tumor lesion(s). Expression of PD-1 and PD-L1 is typically assessed via immunohistochemical detection in a tumor biopsy. However, this method does not take in account the expression heterogeneity within the lesion, nor the possible metastasis. To visualize whole-body PD-L1 expression by PET imaging, we developed a nanobody-based radio-immunotracer targeting PD-L1 site-specifically labeled with gallium-68. The cysteine-tagged nanobody was site-specifically conjugated with a maleimide (mal)-NOTA chelator and radiolabeling was tested at different nanobody concentrations and temperatures. Affinity and specificity of the tracer, referred to as [68Ga]Ga-NOTA-mal-hPD-L1 Nb, were assayed by surface plasmon resonance and on PD-L1POS or PD-L1NEG 624-MEL cells. Xenografted athymic nude mice bearing 624-MEL PD-L1POS or PD-L1NEG tumors were injected with the tracer and ex vivo biodistribution was performed 1 h 20 min post-injection. Ideal 68Ga-labeling conditions were found at 50 °C for 15 min. [68Ga]Ga-NOTA-mal-hPD-L1 Nb was obtained in 80 ± 5% DC-RCY with a RCP > 99%, and was stable in injection buffer and human serum up to 3 h (>99% RCP). The in vitro characterization showed that the NOTA-functionalized Nb retained its affinity and specificity. Ex vivo biodistribution revealed a tracer uptake of 1.86 ± 0.67% IA/g in the positive tumors compared with 0.42 ± 0.04% IA/g in the negative tumors. Low background uptake was measured in the other organs and tissues, except for the kidneys and bladder, due to the expected excretion route of Nbs. The data obtained show that the site-specific 68Ga-labeled NOTA-mal-hPD-L1 Nb is a promising PET radio-immunotracer due to its ease of production, stability and specificity for PD-L1.
- Published
- 2021
- Full Text
- View/download PDF
14. 68Ga-Labeling: Laying the Foundation for an Anti-Radiolytic Formulation for NOTA-sdAb PET Tracers
- Author
-
Henri Baudhuin, Julie Cousaert, Philippe Vanwolleghem, Geert Raes, Vicky Caveliers, Marleen Keyaerts, Tony Lahoutte, and Catarina Xavier
- Subjects
68Ga ,NOTA-sdAb ,radiolysis ,antioxidant ,radioprotectant ,Medicine ,Pharmacy and materia medica ,RS1-441 - Abstract
During the preparation of [68Ga]Ga-NOTA-sdAb at high activity, degradation of the tracers was observed, impacting the radiochemical purity (RCP). Increasing starting activities in radiolabelings is often paired with increased degradation of the tracer due to the formation of free radical species, a process known as radiolysis. Radical scavengers and antioxidants can act as radioprotectant due to their fast interaction with formed radicals and can therefore reduce the degree of radiolysis. This study aims to optimize a formulation to prevent radiolysis during the labeling of NOTA derivatized single domain antibody (sdAbs) with 68Ga. Gentisic acid, ascorbic acid, ethanol and polyvinylpyrrolidone were tested individually or in combination to find an optimal mix able to prevent radiolysis without adversely influencing the radiochemical purity (RCP) or the functionality of the tracer. RCP and degree of radiolysis were assessed via thin layer chromatography and size exclusion chromatography for up to three hours after radiolabeling. Individually, the radioprotectants showed insufficient efficacy in reducing radiolysis when using high activities of 68Ga, while being limited in amount due to negative impact on radiolabeling of the tracer. A combination of 20% ethanol (VEtOH/VBuffer%) and 5 mg ascorbic acid proved successful in preventing radiolysis during labeling with starting activities up to 1–1.2 GBq of 68Ga, and is able to keep the tracer stable for up to at least 3 h after labeling at room temperature. The prevention of radiolysis by the combination of ethanol and ascorbic acid potentially allows radiolabeling compatibility of NOTA-sdAbs with all currently available 68Ge/68Ga generators. Additionally, a design is proposed to allow the incorporation of the radioprotectant in an ongoing diagnostic kit development for 68Ga labeling of NOTA-sdAbs.
- Published
- 2021
- Full Text
- View/download PDF
15. Decorating sdAbs with Chelators: Effect of Conjugation on Biodistribution and Functionality
- Author
-
Henri Baudhuin, Janik Puttemans, Heleen Hanssens, Philippe Vanwolleghem, Sophie Hernot, Geert Raes, Catarina Xavier, Tony Lahoutte, and Pieterjan Debie
- Subjects
bioconjugation ,ion exchange chromatography ,molecular imaging ,radiopharmaceutical ,tracer optimization ,kidney clearance ,Medicine ,Pharmacy and materia medica ,RS1-441 - Abstract
Single domain antibodies (sdAbs) have proven to be valuable probes for molecular imaging. In order to produce such probes, one strategy is the functionalization of the reactive amine side chain of lysines with a chelator, resulting in a mixture of compounds with a different degree of conjugation. In this study, we implemented anion exchange chromatography (AEX) to separate the different compounds or fractions that were further characterized and evaluated to study the impact of the conjugation degree on pharmacokinetic properties and functionality. Anti-HER2 and anti-MMR sdAbs were functionalized with NOTA or DTPA chelator. Anion exchange chromatography was performed using 0.02 mol/L Tris pH 7.5 as the first solvent and 0.25 M or 0.4 M NaCl (in case of NOTA chelator or DTPA chelator, respectively) as the second solvent applied as a gradient. The fractions were characterized via mass spectrometry (MS), surface plasmon resonance (SPR), and isoelectric focusing gel electrophoresis (IEF), while in vivo studies were performed after radiolabeling with either 68Ga (NOTA) or 111In (DTPA) to assess the impact of the conjugation degree on pharmacokinetics. AEX could successfully be applied to separate fractions of (chelator)n-anti-HER2 and (chelator)n-anti-MMR sdAb constructs. MS confirmed the identity of different peaks obtained in the separation process. SPR measurement suggests a small loss of affinity for (chelator)3-anti-sdAb, while IEF revealed a correlated decrease in isoelectric point (pI) with the number of conjugated chelators. Interestingly, both the reduction in affinity and in pI was stronger with the DTPA chelator than with NOTA for both sdAbs. In vivo data showed no significant differences in organ uptake for any construct, except for (DTPA)n-anti-MMR, which showed a significantly higher liver uptake for (DTPA)1-anti-MMR compared to (DTPA)2-anti-MMR and (DTPA)3-anti-MMR. For all constructs in general, high kidney uptake was observed, due to the typical renal clearance of sdAb-based tracers. The kidney uptake showed significant differences between fractions of a same construct and indicates that a higher conjugation degree improves kidney clearance. AEX allows the separation of sdAbs with a different degree of conjugation and provides the opportunity to further characterize individual fractions. The conjugation of a chelator to sdAbs can alter some properties of the tracers, such as pI; however, the impact on the general biodistribution profile and tumor targeting was minimal.
- Published
- 2021
- Full Text
- View/download PDF
16. Atuação farmacêutica em atividades de ensaios clínicos desenvolvidos em um hospital universitário em Salvador Bahia
- Author
-
Da Silva Lima, Milena, primary, Fernandes, Catarina Xavier, additional, Nunes Wildemberg Brauer, Alline Mikaele, additional, Gondim, Daiane, additional, and Kister, Leonardo, additional
- Published
- 2023
- Full Text
- View/download PDF
17. Figure S1 from Theranostic Radiolabeled Anti-CD20 sdAb for Targeted Radionuclide Therapy of Non-Hodgkin Lymphoma
- Author
-
Nick Devoogdt, Jan Tavernier, Tony Lahoutte, José Van Der Heyden, Serge Muyldermans, Kevin Van der Jeught, Catarina Xavier, Matthias D'Huyvetter, and Ahmet Krasniqi
- Abstract
Human CD20 expression on hCD20pos B16 cells was analyzed by flow cytometry. A) 2 x 105 Daudi cells or (B) hCD20pos B16 cells were incubated with 10 µg of Rituximab for 1h at 4{degree sign}C. After washing the cells, Rituximab binding was detected by adding 1 µg of human anti-IgG1 PE mAb (clone IS11-12E4.23.20, Miltenyi Biotec) for 30 min at 4{degree sign}C. After washing, mean fluorescence intensity (MFI) was measured using a FACS Canto Flow Cytometer (BD) and analyzed with Flow Jo 7 software (Tree Star Inc., Ashland, Oregon, USA). Background controls included: unstained Daudi and hCD20pos B16 cells, and Daudi and hCD20pos B16 cells incubated with anti-HER2 Trastuzumab mAb (isotype control) and further processed as described above. C) hCD20-expression was similar for both Daudi and hCD20pos B16 cells.
- Published
- 2023
- Full Text
- View/download PDF
18. Table S5 from Theranostic Radiolabeled Anti-CD20 sdAb for Targeted Radionuclide Therapy of Non-Hodgkin Lymphoma
- Author
-
Nick Devoogdt, Jan Tavernier, Tony Lahoutte, José Van Der Heyden, Serge Muyldermans, Kevin Van der Jeught, Catarina Xavier, Matthias D'Huyvetter, and Ahmet Krasniqi
- Abstract
Ex vivo biodistribution of 68Ga-NOTA-sdAb 9077, 9079 and non-target control sdAb (68Ga-NOTA-ctrl sdAb) at 1.5 h p.i., in hCD20 B16 tumor mouse model. Results are presented as mean % IA/g {plus minus} SD (n = 3 per sdAb).
- Published
- 2023
- Full Text
- View/download PDF
19. Data from Theranostic Radiolabeled Anti-CD20 sdAb for Targeted Radionuclide Therapy of Non-Hodgkin Lymphoma
- Author
-
Nick Devoogdt, Jan Tavernier, Tony Lahoutte, José Van Der Heyden, Serge Muyldermans, Kevin Van der Jeught, Catarina Xavier, Matthias D'Huyvetter, and Ahmet Krasniqi
- Abstract
Anti-CD20 radioimmunotherapy is an effective approach for therapy of relapsed or refractory CD20pos lymphomas, but faces limitations due to poor tumor penetration and undesirable pharmacokinetics of full antibodies. Camelid single-domain Ab fragments (sdAb) might circumvent some of the limitations of radiolabeled full antibodies. In this study, a set of hCD20-targeting sdAbs was generated, and their capacity to bind hCD20 was evaluated in vitro and in vivo. A lead sdAb, sdAb 9079, was selected on the basis of its specific tumor targeting and significant lower kidney accumulation compared with other sdAbs. SdAb 9079 was then radiolabeled with 68Ga and 177Lu for PET imaging and targeted therapy. The therapeutic potential of 177Lu-DTPA-sdAb was compared with that of 177Lu-DTPA-rituximab and unlabeled rituximab in mice bearing hCD20pos tumors. Radiolabeled with 68Ga, sdAb 9079 showed specific tumor uptake, with very low accumulation in nontarget organs, except kidneys. The tumor uptake of 177Lu-DTPA-sdAb 9079 after 1.5 h was 3.4 ± 1.3% ID/g, with T/B and T/M ratios of 13.3 ± 4.6 and 32.9 ± 15.6. Peak tumor accumulation of 177Lu-DTPA-rituximab was about 9 times higher, but concomitantly with high accumulation in nontarget organs and very low T/B and T/M ratios (0.8 ± 0.1 and 7.1 ± 2.4). Treatment of mice with 177Lu-DTPA-sdAb 9079 significantly prolonged median survival compared with control groups and was as effective as treatment with rituximab or its 177Lu-labeled variant. Taken together, sdAb 9079 displays promising features as a theranostic drug to treat CD20pos lymphomas. Mol Cancer Ther; 16(12); 2828–39. ©2017 AACR.
- Published
- 2023
- Full Text
- View/download PDF
20. Supplementary Table S5 from 131I-labeled Anti-HER2 Camelid sdAb as a Theranostic Tool in Cancer Treatment
- Author
-
Nick Devoogdt, Tony Lahoutte, Michael R. Zalutsky, Vicky Caveliers, Geert Raes, Sam Massa, Yann G.J. Sterckx, Marek Pruszynski, Catarina Xavier, Jens De Vos, and Matthias D'Huyvetter
- Abstract
Supplementary Table S5 shows the ex vivo biodistribution of 131I-2Rs15d after 1h in mice with BT474/M1 xenografts that were pre-treated 72h earlier with a 100-fold molar excess of trastuzumab, pertuzumab or a combination of both.
- Published
- 2023
- Full Text
- View/download PDF
21. Data from 131I-labeled Anti-HER2 Camelid sdAb as a Theranostic Tool in Cancer Treatment
- Author
-
Nick Devoogdt, Tony Lahoutte, Michael R. Zalutsky, Vicky Caveliers, Geert Raes, Sam Massa, Yann G.J. Sterckx, Marek Pruszynski, Catarina Xavier, Jens De Vos, and Matthias D'Huyvetter
- Abstract
Purpose: Camelid single-domain antibody-fragments (sdAb) have beneficial pharmacokinetic properties, and those targeted to HER2 can be used for imaging of HER2-overexpressing cancer. Labeled with a therapeutic radionuclide, they may be used for HER2-targeted therapy. Here, we describe the generation of a 131I-labeled sdAb as a theranostic drug to treat HER2-overexpressing cancer.Experimental Design: Anti-HER2 sdAb 2Rs15d was labeled with 131I using [131I]SGMIB and evaluated in vitro. Biodistribution was evaluated in two HER2+ murine xenograft models by micro-SPECT/CT imaging and at necropsy, and under challenge with trastuzumab and pertuzumab. The therapeutic potential of [131I]SGMIB-2Rs15d was investigated in two HER2+ tumor mouse models. A single-dose toxicity study was performed in mice using unlabeled [127I]SGMIB-sdAb at 1.4 mg/kg. The structure of the 2Rs15d–HER2 complex was determined by X-ray crystallography.Results: [131I]SGMIB-2Rs15d bound specifically to HER2+ cells (Kd = 4.74 ± 0.39 nmol/L). High and specific tumor uptake was observed in both BT474/M1 and SKOV-3 tumor xenografted mice and surpassed kidney levels by 3 hours. Extremely low uptake values were observed in other normal tissues at all time points. The crystal structure revealed that 2Rs15d recognizes HER2 Domain 1, consistent with the lack of competition with trastuzumab and pertuzumab observed in vivo. [131I]SGMIB-2Rs15d alone, or in combination with trastuzumab, extended median survival significantly. No toxicity was observed after injecting [127I]SGMIB-2Rs15d.Conclusions: These findings demonstrate the theranostic potential of [131I]SGMIB-2Rs15d. An initial scan using low radioactive [*I]SGMIB-2Rs15d allows patient selection and dosimetry calculations for subsequent therapeutic [131I]SGMIB-2Rs15d and could thereby impact therapy outcome on HER2+ breast cancer patients. Clin Cancer Res; 23(21); 6616–28. ©2017 AACR.
- Published
- 2023
- Full Text
- View/download PDF
22. Supplemental Materials and Methods from 131I-labeled Anti-HER2 Camelid sdAb as a Theranostic Tool in Cancer Treatment
- Author
-
Nick Devoogdt, Tony Lahoutte, Michael R. Zalutsky, Vicky Caveliers, Geert Raes, Sam Massa, Yann G.J. Sterckx, Marek Pruszynski, Catarina Xavier, Jens De Vos, and Matthias D'Huyvetter
- Abstract
A detailed description of the materials and methods used for the HER2-2Rs15d structure determination, the radioiodination of sdAbs, and all flow cytometry experiments.
- Published
- 2023
- Full Text
- View/download PDF
23. Supplementary figure S1 from 131I-labeled Anti-HER2 Camelid sdAb as a Theranostic Tool in Cancer Treatment
- Author
-
Nick Devoogdt, Tony Lahoutte, Michael R. Zalutsky, Vicky Caveliers, Geert Raes, Sam Massa, Yann G.J. Sterckx, Marek Pruszynski, Catarina Xavier, Jens De Vos, and Matthias D'Huyvetter
- Abstract
Supplementary figure S1 details the HER2-epitope recognized by 2Rs15d compared to those reported for other described HER2-binders and a view of HER2-ÂÃ,â2Rs15d interactions.
- Published
- 2023
- Full Text
- View/download PDF
24. Anti-Human PD-L1 Nanobody for Immuno-PET Imaging: Validation of a Conjugation Strategy for Clinical Translation
- Author
-
Jessica Bridoux, Katrijn Broos, Quentin Lecocq, Pieterjan Debie, Charlotte Martin, Steven Ballet, Geert Raes, Sara Neyt, Christian Vanhove, Karine Breckpot, Nick Devoogdt, Vicky Caveliers, Marleen Keyaerts, and Catarina Xavier
- Subjects
Nanobody ,PD-L1 ,site-specific ,PET ,gallium-68 ,Sortase A ,Microbiology ,QR1-502 - Abstract
Immune checkpoints, such as programmed death-ligand 1 (PD-L1), limit T-cell function and tumor cells use this ligand to escape the anti-tumor immune response. Treatments with monoclonal antibodies blocking these checkpoints have shown long-lasting responses, but only in a subset of patients. This study aims to develop a Nanobody (Nb)-based probe in order to assess human PD-L1 (hPD-L1) expression using positron emission tomography imaging, and to compare the influence of two different radiolabeling strategies, since the Nb has a lysine in its complementarity determining region (CDR), which may impact its affinity upon functionalization. The Nb has been conjugated with the NOTA chelator site-specifically via the Sortase-A enzyme or randomly on its lysines. [68Ga]Ga-NOTA-(hPD-L1) Nbs were obtained in >95% radiochemical purity. In vivo tumor targeting studies at 1 h 20 post-injection revealed specific tumor uptake of 1.89 ± 0.40%IA/g for the site-specific conjugate, 1.77 ± 0.29%IA/g for the random conjugate, no nonspecific organ targeting, and excretion via the kidneys and bladder. Both strategies allowed for easily obtaining 68Ga-labeled hPD-L1 Nbs in high yields. The two conjugates were stable and showed excellent in vivo targeting. Moreover, we proved that the random lysine-conjugation is a valid strategy for clinical translation of the hPD-L1 Nb, despite the lysine present in the CDR.
- Published
- 2020
- Full Text
- View/download PDF
25. Improved Detection of Molecular Markers of Atherosclerotic Plaques Using Sub-Millimeter PET Imaging
- Author
-
Jessica Bridoux, Sara Neyt, Pieterjan Debie, Benedicte Descamps, Nick Devoogdt, Frederik Cleeren, Guy Bormans, Alexis Broisat, Vicky Caveliers, Catarina Xavier, Christian Vanhove, and Sophie Hernot
- Subjects
vulnerable plaque ,molecular imaging ,PET imaging ,nanobody ,single-domain antibody ,sub-millimetre resolution ,Organic chemistry ,QD241-441 - Abstract
Since atherosclerotic plaques are small and sparse, their non-invasive detection via PET imaging requires both highly specific radiotracers as well as imaging systems with high sensitivity and resolution. This study aimed to assess the targeting and biodistribution of a novel fluorine-18 anti-VCAM-1 Nanobody (Nb), and to investigate whether sub-millimetre resolution PET imaging could improve detectability of plaques in mice. The anti-VCAM-1 Nb functionalised with the novel restrained complexing agent (RESCA) chelator was labelled with [18F]AlF with a high radiochemical yield (>75%) and radiochemical purity (>99%). Subsequently, [18F]AlF(RESCA)-cAbVCAM1-5 was injected in ApoE−/− mice, or co-injected with excess of unlabelled Nb (control group). Mice were imaged sequentially using a cross-over design on two different commercially available PET/CT systems and finally sacrificed for ex vivo analysis. Both the PET/CT images and ex vivo data showed specific uptake of [18F]AlF(RESCA)-cAbVCAM1-5 in atherosclerotic lesions. Non-specific bone uptake was also noticeable, most probably due to in vivo defluorination. Image analysis yielded higher target-to-heart and target-to-brain ratios with the β-CUBE (MOLECUBES) PET scanner, demonstrating that preclinical detection of atherosclerotic lesions could be improved using the latest PET technology.
- Published
- 2020
- Full Text
- View/download PDF
26. Iris melanocytoma and secondary glaucoma
- Author
-
Catarina Xavier, Ana Magriço, Diogo Hipólito-Fernandes, and Joana Cardigos
- Subjects
0301 basic medicine ,medicine.medical_specialty ,genetic structures ,medicine.medical_treatment ,Ultrasound biomicroscopy ,Microscopy, Acoustic ,Glaucoma ,Trabeculectomy ,Case Report ,Cataract Extraction ,030105 genetics & heredity ,Pupil ,03 medical and health sciences ,0302 clinical medicine ,Ophthalmology ,medicine ,Humans ,Iris (anatomy) ,Iris Neoplasms ,Intraocular Pressure ,Aged ,Nevus, Pigmented ,Corectopia ,business.industry ,General Medicine ,Cataract surgery ,medicine.disease ,eye diseases ,medicine.anatomical_structure ,Melanocytes ,Female ,sense organs ,medicine.symptom ,Melanocytoma ,business ,Glaucoma, Angle-Closure ,030217 neurology & neurosurgery - Abstract
Iris melanocytoma (IM) is a rare variant of iris nevus with distinctive clinical and histopathological features. A 66-year-old woman, with a history of right eye pigmented iris nevus, presented to us with a recent onset of visual acuity decrease in that eye. She had a melanocytic iris lesion with iridocorneal angle invasion, peripheral corneal adhesion, pupil corectopia, sectorial cataract and high intraocular pressure. Ultrasound biomicroscopy did not exclude malignant transformation, so excisional biopsy was performed revealing the presence of IM without signs of atypia. Subsequently, the patient underwent cataract surgery combined with iridoplasty and later an ab externo trabeculectomy. Most cases of IM remain stable and require no intervention, but in cases of unusual clinical course, with rapid growth or secondary glaucoma, surgical treatment is indicated as a diagnostic and therapeutic measure. This case report highlights the importance of a timely and multidisciplinary ophthalmological approach for a better visual outcome.
- Published
- 2022
27. Lyophilization of NOTA-sdAbs: First step towards a cold diagnostic kit for 68Ga-labeling
- Author
-
Nick Devoogdt, Jessica Bridoux, Catarina Xavier, Pieter-Jan Van Bockstal, Ilse Vaneycken, Marleen Keyaerts, Vicky Caveliers, Tony Lahoutte, Thomas De Beer, Geert Raes, Henri Baudhuin, Supporting clinical sciences, Faculty of Medicine and Pharmacy, Medical Imaging, Nuclear Medicine, Cellular and Molecular Immunology, and Clinical sciences
- Subjects
Biodistribution ,PET imaging ,Pharmaceutical Science ,02 engineering and technology ,030226 pharmacology & pharmacy ,Polyvinyl alcohol ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Cold kit ,In vivo ,Distribution (pharmacology) ,Medicine(all) ,Active ingredient ,Chromatography ,Gallium-68 ,Significant difference ,General Medicine ,Pet imaging ,021001 nanoscience & nanotechnology ,Lyophilization ,In vitro ,chemistry ,Radiology Nuclear Medicine and imaging ,Radiopharmaceuticals ,0210 nano-technology ,Biotechnology - Abstract
Lyophilization is commonly used in the production of pharmaceutical compounds to increase the stability of the Active Pharmaceutical Ingredient (API) by removing solvents. This study investigates the possibility to lyophilize an anti-HER2 and an anti-MMR single-domain antibody fragment (sdAb)-based precursor as a first step in the development of a diagnostic kit for PET imaging. Methods NOTA-sdAb precursors have been lyophilized with the following formulation: 100 µg NOTA-sdAb in 0.1 M NaOAc (NaOAc), 5% (w/v%) mannitol-sucrose mix at a 2:1 ratio and 0.1 mg/mL polysorbate 80. During development of the formulation and drying cycle, factors such as cake appearance, glass transition temperature and residual moisture were analyzed to ensure qualitative and stable lyophilized samples. Stability studies of lyophilized precursor were conducted up to 18 months after storage at 2–8 °C by evaluating the precursor integrity, aggregation, functionality and 68Ga-labeling efficiency. A comparative biodistribution study (lyophilized vs non-lyophilized precursor) was conducted in wild type mice (n = 3) and in tumor bearing mice (n = 6). Results The lyophilized NOTA-anti-HER2 precursor shows consistent stability data in vitro for up to 12 months at 2–8 °C in three separate batches, with results indicating stability even for up to T18m. No aggregation, degradation or activity loss was observed. Radiochemical purity after 68Ga-labeling is consistent over a period of 12 months (RCP ≥ 95% at T12m). In vivo biodistribution analyses show a typical [68Ga]Ga-NOTA-anti-HER2 sdAb distribution profile and a comparable tumor uptake for the lyophilized compound vs non-lyophilized (5.5% vs 5.7 %IA/g, respectively). In vitro results of lyophilized NOTA-anti-MMR precursor indicates stability for up to 18 months, while in vivo data show a comparable tumor uptake (2.5% vs 2.8 %IA/g, respectively) and no significant difference in kidney retention (49.4% vs 47.5 %IA/g, respectively). Conclusion A formulation and specific freeze-drying cycle were successfully developed to lyophilize NOTA-sdAb precursors for long-term storage at 2–8 °C. In vivo data show no negative impact of the lyophilization process on the in vivo behavior or functionality of the lyophilized precursor. These results highlight the potential to develop a kit for the preparation of 68Ga-sdAb-based radiopharmaceuticals.
- Published
- 2021
- Full Text
- View/download PDF
28. On norms and taboo
- Author
-
Catarina Xavier
- Subjects
Typology ,050101 languages & linguistics ,Linguistics and Language ,Communication ,media_common.quotation_subject ,05 social sciences ,Taboo ,050801 communication & media studies ,Qualitative property ,Language and Linguistics ,Linguistics ,language.human_language ,0508 media and communications ,Empirical research ,language ,Translation studies ,0501 psychology and cognitive sciences ,Relevance (information retrieval) ,Norm (social) ,Portuguese ,Psychology ,media_common - Abstract
Within Audiovisual Translation Studies, many studies have been dedicated to the subtitling of taboo words. Most of this research has been restricted to quantitative and qualitative data about translation strategies, with comparably less attention given to translation norms. As norms cannot be directly observed, their investigation raises methodological challenges for empirical studies. This paper proposes a model for the investigation of translation norms by triangulating data on observed regularities in the English to Portuguese subtitling of taboo words in a corpus of movies broadcast on Portuguese FTA (free-to-air, open-signal) television between 2001 and 2015, with questionnaire data on subtitlers’ attitudes towards the subtitling of taboo words on television. The results enable the identification of the most frequent subtitling strategies, their possible motivations, and the relevance of two contextual variables (time period and channel typology). Using the results, a (potential) norm regarding the subtitling of taboo words in Portugal is formulated. However, some of the data, both textual and extratextual, raise the question of whether there is also a competing norm at play.
- Published
- 2021
- Full Text
- View/download PDF
29. Corneal Subbasal Nerve Plexus Evaluation by in Vivo Confocal Microscopy in Multiple Sclerosis: A Potential New Biomarker
- Author
-
Joana Cardigos, João Paulo Cunha, Maria Elisa Luís, Joana Tavares Ferreira, Diogo Hipólito Fernandes, Catarina Xavier, Marta Alves, and Ana Luísa Papoila
- Subjects
Pathology ,medicine.medical_specialty ,genetic structures ,In vivo confocal microscopy ,law.invention ,Multiple sclerosis ,03 medical and health sciences ,Cellular and Molecular Neuroscience ,0302 clinical medicine ,Optical coherence tomography ,In vivo ,Confocal microscopy ,law ,medicine ,Expanded Disability Status Scale ,medicine.diagnostic_test ,business.industry ,Nerve plexus ,medicine.disease ,eye diseases ,Sensory Systems ,Ophthalmology ,medicine.anatomical_structure ,030221 ophthalmology & optometry ,Biomarker (medicine) ,Corneal subbasal nerve plexus ,sense organs ,business ,030217 neurology & neurosurgery ,Orthoptics - Abstract
Submitted by Maria da Luz Antunes (mluz.antunes@estesl.ipl.pt) on 2021-08-04T14:37:34Z No. of bitstreams: 1 Corneal subbasal nerve plexus evaluation by in vivo confocal microscopy in multiple sclerosis.pdf: 1317032 bytes, checksum: 86be831615d41642d36aa9409b5f2dd8 (MD5) Made available in DSpace on 2021-08-04T14:37:34Z (GMT). No. of bitstreams: 1 Corneal subbasal nerve plexus evaluation by in vivo confocal microscopy in multiple sclerosis.pdf: 1317032 bytes, checksum: 86be831615d41642d36aa9409b5f2dd8 (MD5) Previous issue date: 2021-04 info:eu-repo/semantics/publishedVersion
- Published
- 2021
- Full Text
- View/download PDF
30. Evidence for multi-copy Mega-NUMTsin the human genome
- Author
-
Matthias Schmuth, Sandra Carina Weiß, Thomas Liehr, Jana Naue, Stefan Pollak, Timo Sänger, Fengtang Yang, Jodi A. Irwin, Peter Lichter, Cordula Berger, Pidder Jansen-Dürr, Erica L. Romsos, Marianne Volleth, Thomas J. Parsons, René Pflugradt, Rafal Koziel, Christina Strobl, Sabine Lutz-Bonengel, Catarina Xavier, Gabriela Huber, Peter M. Vallone, Walther Parson, Harald Niederstätter, and Gudrun Ratzinger
- Subjects
Male ,Mitochondrial DNA ,DNA Copy Number Variations ,AcademicSubjects/SCI00010 ,Mitochondrial disease ,Biology ,DNA, Mitochondrial ,Genome ,Haplogroup ,03 medical and health sciences ,0302 clinical medicine ,Genetics ,medicine ,Humans ,030216 legal & forensic medicine ,030304 developmental biology ,Cell Nucleus ,0303 health sciences ,Massive parallel sequencing ,Genome, Human ,Sequence Analysis, DNA ,Genomics ,medicine.disease ,Human genetics ,Pedigree ,Nuclear DNA ,Female ,Human genome - Abstract
The maternal mode of mitochondrial DNA (mtDNA) inheritance is central to human genetics. Recently, evidence for bi-parental inheritance of mtDNA was claimed for individuals of three pedigrees that suffered mitochondrial disorders. We sequenced mtDNA using both direct Sanger and Massively Parallel Sequencing in several tissues of eleven maternally related and other affiliated healthy individuals of a family pedigree and observed mixed mitotypes in eight individuals. Cells without nuclear DNA, i.e. thrombocytes and hair shafts, only showed the mitotype of haplogroup (hg) V. Skin biopsies were prepared to generate ρ° cells void of mtDNA, sequencing of which resulted in a hg U4c1 mitotype. The position of the Mega-NUMT sequence was determined by fluorescence in situ hybridization and two different quantitative PCR assays were used to determine the number of contributing mtDNA copies. Thus, evidence for the presence of repetitive, full mitogenome Mega-NUMTs matching haplogroup U4c1 in various tissues of eight maternally related individuals was provided. Multi-copy Mega-NUMTs mimic mixtures of mtDNA that cannot be experimentally avoided and thus may appear in diverse fields of mtDNA research and diagnostics. We demonstrate that hair shaft mtDNA sequencing provides a simple but reliable approach to exclude NUMTs as source of misleading results.
- Published
- 2021
- Full Text
- View/download PDF
31. A Review of Neuro-Ophthalmological Manifestations of Human Coronavirus Infection
- Author
-
Maria Elisa Luís, Diogo Maleita, Catarina Mota, Diogo Hipólito-Fernandes, João Paulo Cunha, Tiago Maio, Catarina Xavier, and Joana Tavares Ferreira
- Subjects
Pediatrics ,medicine.medical_specialty ,genetic structures ,Visual impairment ,Disease ,Nystagmus ,medicine.disease_cause ,law.invention ,Cellular and Molecular Neuroscience ,law ,medicine ,Coronaviridae ,Coronavirus ,Diplopia ,biology ,business.industry ,virus diseases ,medicine.disease ,biology.organism_classification ,Intensive care unit ,eye diseases ,Sensory Systems ,Ophthalmology ,medicine.symptom ,business ,Encephalitis - Abstract
Introduction Human coronavirus (HCoVs) are a group of viruses with recognized neurotropic and neuroinvasive capabilities. The reports on the neurological and ocular findings are increasing day after day and several central and peripheral neurological manifestations are already described. However, none specifically describes the neuro-ophthalmological manifestation of HCoVs. This is the first article specifically reviewing neuro-ophthalmological manifestations of HCoVs infection. Methods PubMed and Google Scholar databases were searched using the keywords: coronaviridae, coronavirus, COVID-19, SARS-CoV-2, SARS-CoV-1, MERS, ocular, ophthalmology, ophthalmological, neuro-ophthalmology, neurological, manifestations. A manual search through the reference lists of relevant articles was also performed. There were no restrictions concerning language or study type and publications not yet printed but available online were considered. Results Coronavirus eye involvement is not frequent and includes mostly a typical viral follicular conjunctivitis. Recently, retinal anatomical alterations were described using optic coherence tomography. Neuro-ophthalmological symptoms and signs can appear isolated or associated with neurological syndromes. The manifestations include headache, ocular pain, visual impairment, diplopia, and cranial nerve palsies secondary to Miller Fisher syndrome, Guillain-Barre syndrome, or encephalitis, and nystagmus. Conclusion Neurological and neuro-ophthalmological syndromes, symptoms, and signs should not be neglected and a complete ophthalmological examination of these patients should be performed to fully describe ocular manifestations related to HCoVs. We believe that major ocular and neuro-ophthalmological manifestations reports lack due to safety issues concerning detailed ophthalmological examination; on the other hand, in a large number of cases, the presence of life-threatening coronavirus disease hinders ocular examination and ophthalmologist's visit to the intensive care unit.
- Published
- 2020
- Full Text
- View/download PDF
32. Therapeutic Efficacy of 213Bi-labeled sdAbs in a Preclinical Model of Ovarian Cancer
- Author
-
Frank Bruchertseifer, Peter Covens, Mireille Gysemans, Yana Dekempeneer, Catarina Xavier, Quentin Lecocq, Vicky Caveliers, Thomas Cardinaels, Maarten Ooms, Ken Maes, Brian Miller, Tony Lahoutte, Matthias D'Huyvetter, Dominic Maertens, Alfred Morgenstern, Medical Imaging, Faculty of Medicine and Pharmacy, Supporting clinical sciences, Translational Imaging Research Alliance, Nuclear Medicine, Cyclotron, Clinical sciences, Basic (bio-) Medical Sciences, Medical Genetics, Hematology, Preventie- & Milieudienst, and UZB Other
- Subjects
business.industry ,Pharmaceutical Science ,Cancer ,02 engineering and technology ,021001 nanoscience & nanotechnology ,medicine.disease ,030226 pharmacology & pharmacy ,In vitro ,Radioconjugate ,03 medical and health sciences ,0302 clinical medicine ,In vivo ,Trastuzumab ,Drug Discovery ,Toxicity ,Cancer research ,medicine ,Molecular Medicine ,Cytotoxic T cell ,0210 nano-technology ,Ovarian cancer ,business ,medicine.drug - Abstract
Targeted alpha-particle therapy (TAT) might be a relevant therapeutic strategy to circumvent resistance to conventional therapies in the case of HER2-positive metastatic cancer. Single-domain antibody fragments (sdAb) are promising vehicles for TAT because of their excellent in vivo properties, high target affinity, and fast clearance kinetics. This study combines the cytotoxic α-particle emitter bismuth-213 (213Bi) and HER2-targeting sdAbs. The in vitro specificity, affinity, and cytotoxic potency of the radiolabeled complex were analyzed on HER2pos cells. Its in vivo biodistribution through serial dissections and via Cherenkov and micro-single-photon emission computed tomography (CT)/CT imaging was evaluated. Finally, the therapeutic efficacy and potential associated toxicity of [213Bi]Bi-DTPA-2Rs15d were evaluated in a HER2pos tumor model that manifests peritoneal metastasis. In vitro, [213Bi]Bi-DTPA-2Rs15d bound HER2pos cells in a HER2-specific way. In mice, high tumor uptake was reached already 15 min after injection, and extremely low uptake values were observed in normal tissues. Co-infusion of gelofusine resulted in a 2-fold reduction in kidney uptake. Administration of [213Bi]Bi-DTPA-2Rs15d alone and in combination with trastuzumab resulted in a significant increase in median survival. We describe for the very first time the successful labeling of an HER2-sdAb with the α-emitter 213Bi, and after intravenous administration, revealing high in vivo stability and specific accumulation in target tissue and resulting in an increased median survival of these mice especially in combination with trastuzumab. These results indicate the potential of [213Bi]Bi-DTPA-sdAb as a new radioconjugate for TAT, alone and as an add-on to trastuzumab for the treatment of HER2pos metastatic cancer.
- Published
- 2020
- Full Text
- View/download PDF
33. Reshaping nanobodies for affinity purification on protein a
- Author
-
Nick Devoogdt, Catarina Xavier, Neeme Benedict Kulaya, Nele Van Vaerenbergh, Maxine Crauwels, Serge Muyldermans, Matthias D'Huyvetter, Cécile Vincke, Medical Imaging, Cellular and Molecular Immunology, Vrije Universiteit Brussel, Supporting clinical sciences, Translational Imaging Research Alliance, and Clinical sciences
- Subjects
0106 biological sciences ,Staphylococcus aureus ,Biodistribution ,Protein A ,Bioengineering ,Affinity chromatography ,medicine.disease_cause ,01 natural sciences ,Chromatography, Affinity ,law.invention ,03 medical and health sciences ,Antigen ,law ,010608 biotechnology ,medicine ,Staphylococcal Protein A ,Molecular Biology ,030304 developmental biology ,Thermostability ,Medicine(all) ,0303 health sciences ,biology ,Chemistry ,food and beverages ,General Medicine ,Single-Domain Antibodies ,Biochemistry ,embryonic structures ,Nanobody ,biology.protein ,Recombinant DNA ,Antibody ,Biotechnology - Abstract
Nanobodies (Nbs) are 15 kDa recombinant, single-domain, antigen-specific fragments derived from heavy-chain only antibodies (HCAbs) occurring naturally in species of Camelidae. The beneficial properties of Nbs make them suitable tracers for diagnostic and therapeutic purposes. Whereas Nbs with a terminal hexa-histidine tag (His-tag) are easily purified via immobilized metal affinity chromatography, previous studies revealed a negative impact of the His-tag on the biodistribution of Nb-based tracers. Thus, it is important to develop alternative purification methods for Nbs without a His-tag. Protein A (SpA), a surface protein of Staphylococcus aureus, binds the Fc-region of IgG molecules and also to a lesser extent human heavy chain family-3 variable (VH) regions. Nbs also belong to this VH family, although many fail to be recognized by SpA. Here it is demonstrated that non-SpA binding Nbs can be mutagenized for purification by SpA affinity chromatography and that these Nb variants retain their thermostability and antigen affinity, while biodistribution remains unaffected.
- Published
- 2020
- Full Text
- View/download PDF
34. Horizontal Gaze Palsy and Progressive Scoliosis in Dizygotic Twins
- Author
-
Catarina, Xavier, Miguel, Vieira, Ana Filipa, Duarte, Ana, Xavier, and Eduardo D, Silva
- Subjects
Strabismus ,Ophthalmoplegia, Chronic Progressive External ,Ocular Motility Disorders ,Scoliosis ,Twins, Dizygotic ,Humans ,Receptors, Cell Surface ,Magnetic Resonance Imaging - Abstract
Horizontal gaze palsy and progressive scoliosis (HGPPS) is a rare autosomal recessive disorder caused by mutations in the
- Published
- 2022
35. The multifaceted genomic history of Ashaninka from Amazonian Peru
- Author
-
Marco Rosario Capodiferro, Ana María Chero Osorio, Nicola Rambaldi Migliore, Dean Herman Tineo Tineo, Alessandro Raveane, Catarina Xavier, Martin Bodner, Filipa Simão, Linda Ongaro, Francesco Montinaro, John Lindo, Emilia Huerta-Sanchez, Gustavo Politis, Chiara Barbieri, Walther Parson, Leonor Gusmão, Alessandro Achilli, and University of Zurich
- Subjects
UFSP13-7 Evolution in Action: From Genomes to Ecosystems ,10127 Institute of Evolutionary Biology and Environmental Studies ,General Biochemistry ,570 Life sciences ,biology ,590 Animals (Zoology) ,Genetics and Molecular Biology ,General Agricultural and Biological Sciences ,EVOL NCCR Evolving Language ,General Biochemistry, Genetics and Molecular Biology - Published
- 2023
- Full Text
- View/download PDF
36. Ensino-pesquisa-extensão: um exercício de indissociabilidade no projeto Qr Code
- Author
-
Catarina Xavier Lopes da Silva, Laura Franco Gonçalves Procaci, and Melissa Anselmo dos Santos
- Published
- 2022
- Full Text
- View/download PDF
37. Helena's Many Daughters: More Mitogenome Diversity behind the Most Common West Eurasian mtDNA Control Region Haplotype in an Extended Italian Population Sample
- Author
-
Martin Bodner, Christina Amory, Anna Olivieri, Francesca Gandini, Irene Cardinali, Hovirag Lancioni, Gabriela Huber, Catarina Xavier, Maria Pala, Alessandro Fichera, Lisa Schnaller, Mario Gysi, Stefania Sarno, Davide Pettener, Donata Luiselli, Martin B. Richards, Ornella Semino, Alessandro Achilli, Antonio Torroni, Walther Parson, Bodner, Martin, Amory, Christina, Olivieri, Anna, Gandini, Francesca, Cardinali, Irene, Lancioni, Hovirag, Huber, Gabriela, Xavier, Catarina, Pala, Maria, Fichera, Alessandro, Schnaller, Lisa, Gysi, Mario, Sarno, Stefania, Pettener, Davide, Luiselli, Donata, Richards, Martin B, Semino, Ornella, Achilli, Alessandro, Torroni, Antonio, Parson, Walther, and University of Zurich
- Subjects
1503 Catalysis ,mtDNA haplogroup ,340 Law ,1607 Spectroscopy ,mtDNA haplogroup H ,610 Medicine & health ,Pilot Projects ,DNA, Mitochondrial ,Catalysis ,Nuclear Family ,Inorganic Chemistry ,1312 Molecular Biology ,1706 Computer Science Applications ,power of discrimination ,Physical and Theoretical Chemistry ,Molecular Biology ,Spectroscopy ,massively parallel sequencing ,next-generation sequencing ,forensics ,most common haplotype ,random match probability ,1604 Inorganic Chemistry ,Organic Chemistry ,General Medicine ,Sequence Analysis, DNA ,forensic ,10218 Institute of Legal Medicine ,Computer Science Applications ,Genetics, Population ,Haplotypes ,Genome, Mitochondrial ,1606 Physical and Theoretical Chemistry ,1605 Organic Chemistry - Abstract
The high number of matching haplotypes of the most common mitochondrial (mt)DNA lineages are considered to be the greatest limitation for forensic applications. This study investigates the potential to solve this constraint by massively parallel sequencing a large number of mitogenomes that share the most common West Eurasian mtDNA control region (CR) haplotype motif (263G 315.1C 16519C). We augmented a pilot study on 29 to a total of 216 Italian mitogenomes that represents the largest set of the most common CR haplotype compiled from a single country. The extended population sample confirmed and extended the huge coding region diversity behind the most common CR motif. Complete mitogenome sequencing allowed for the detection of 163 distinct haplotypes, raising the power of discrimination from 0 (CR) to 99.6% (mitogenome). The mtDNAs were clustered into 61 named clades of haplogroup H and did not reveal phylogeographic trends within Italy. Rapid individualization approaches for investigative purposes are limited to the most frequent H clades of the dataset, viz. H1, H3, and H7.
- Published
- 2022
38. The Ancestry of Eastern Paraguay: A Typical South American Profile with a Unique Pattern of Admixture
- Author
-
Carlos Vullo, Alfredo Quiroz, Walther Parson, Leonor Gusmão, Ana Paula Ferreira, Laura Catelli, Verónica Gomes, Elizeu Fagundes de Carvalho, Gabriela Huber, Filipa Simão, Catarina Xavier, Martin Bodner, and Julyana Ribeiro
- Subjects
Male ,Human Migration ,AIM-InDels ,Population ,QH426-470 ,Joint analysis ,Demographic data ,DNA, Mitochondrial ,Polymorphism, Single Nucleotide ,Haplogroup ,Indigenous ,Article ,Evolution, Molecular ,Parana river ,Genetics ,Humans ,Genetics (clinical) ,Chromosomes, Human, Y ,Y chromosome ,Native american ,mtDNA ,ancestry ,Racial Groups ,Y-STRs ,Y-SNPs ,Colonial period ,Pedigree ,Geography ,Paraguay ,South american ,Female ,Demography ,Microsatellite Repeats - Abstract
Immigrants from diverse origins have arrived in Paraguay and produced important demographic changes in a territory initially inhabited by indigenous Guarani. Few studies have been performed to estimate the proportion of Native ancestry that is still preserved in Paraguay and the role of females and males in admixture processes. Therefore, 548 individuals from eastern Paraguay were genotyped for three marker sets: mtDNA, Y-SNPs and autosomal AIM-InDels. A genetic homogeneity was found between departments for each set of markers, supported by the demographic data collected, which showed that only 43% of the individuals have the same birthplace as their parents. The results show a sex-biased intermarriage, with higher maternal than paternal Native American ancestry. Within the native mtDNA lineages in Paraguay (87.2% of the total), most haplogroups have a broad distribution across the subcontinent, and only few are concentrated around the Paraná River basin. The frequency distribution of the European paternal lineages in Paraguay (92.2% of the total) showed a major contribution from the Iberian region. In addition to the remaining legacy of the colonial period, the joint analysis of the different types of markers included in this study revealed the impact of post-war migrations on the current genetic background of Paraguay.
- Published
- 2021
39. Admixture and genetic diversity distribution patterns of non-recombining lineages of Native American ancestry in Colombian populations.
- Author
-
Catarina Xavier, Juan José Builes, Verónica Gomes, Jose Miguel Ospino, Juliana Aquino, Walther Parson, António Amorim, Leonor Gusmão, and Ana Goios
- Subjects
Medicine ,Science - Abstract
Genetic diversity of present American populations results from very complex demographic events involving different types and degrees of admixture. Through the analysis of lineage markers such as mtDNA and Y chromosome it is possible to recover the original Native American haplotypes, which remained identical since the admixture events due to the absence of recombination. However, the decrease in the effective population sizes and the consequent genetic drift effects suffered by these populations during the European colonization resulted in the loss or under-representation of a substantial fraction of the Native American lineages. In this study, we aim to clarify how the diversity and distribution of uniparental lineages vary with the different demographic characteristics (size, degree of isolation) and the different levels of admixture of extant Native groups in Colombia. We present new data resulting from the analyses of mtDNA whole control region, Y chromosome SNP haplogroups and STR haplotypes, and autosomal ancestry informative insertion-deletion polymorphisms in Colombian individuals from different ethnic and linguistic groups. The results demonstrate that populations presenting a high proportion of non-Native American ancestry have preserved nevertheless a substantial diversity of Native American lineages, for both mtDNA and Y chromosome. We suggest that, by maintaining the effective population sizes high, admixture allowed for a decrease in the effects of genetic drift due to Native population size reduction and thus resulting in an effective preservation of the Native American non-recombining lineages.
- Published
- 2015
- Full Text
- View/download PDF
40. Evaluation of mitogenome sequence concordance, heteroplasmy detection, and haplogrouping in a worldwide lineage study using the Precision ID mtDNA Whole Genome Panel
- Author
-
Leonor Gusmão, Bruce Budowle, Carlos Vullo, Jennifer Churchill Cihlar, Reinhard Würzner, Seah Lay Hong, Claudia Barletta-Carrillo, Wiliam Usaquén, Bettina Zimmermann, Rosane Silva, Chantal Roth, Martin Bodner, Harald Niederstätter, Rodrigo S. Moura-Neto, L. Souto, Gabriela Huber, Robert Lagacé, Dayse A. Silva, Christina Strobl, Balázs Egyed, Walther Parson, Dean Herman Tineo, Andrea Casas-Vargas, Catarina Xavier, Katja Anslinger, Farida Alshamali, Lisa Schnaller, Sharon Wootton, Renata Jankova-Ajanovska, and Nicole Huber
- Subjects
Forensic Genetics ,0301 basic medicine ,Mitochondrial DNA ,Computational biology ,Biology ,DNA, Mitochondrial ,Genome ,DNA sequencing ,Haplogroup ,Pathology and Forensic Medicine ,03 medical and health sciences ,symbols.namesake ,0302 clinical medicine ,Genetics ,Humans ,030216 legal & forensic medicine ,Phylogeny ,Sanger sequencing ,Massive parallel sequencing ,Phylogenetic tree ,High-Throughput Nucleotide Sequencing ,Sequence Analysis, DNA ,Heteroplasmy ,030104 developmental biology ,Haplotypes ,Genome, Mitochondrial ,symbols ,Multiplex Polymerase Chain Reaction - Abstract
The emergence of Massively Parallel Sequencing technologies enabled the analysis of full mitochondrial (mt)DNA sequences from forensically relevant samples that have, so far, only been typed in the control region or its hypervariable segments. In this study, we evaluated the performance of a commercially available multiplex-PCR-based assay, the Precision ID mtDNA Whole Genome Panel (Thermo Fisher Scientific), for the amplification and sequencing of the entire mitochondrial genome (mitogenome) from even degraded forensic specimens. For this purpose, more than 500 samples from 24 different populations were selected to cover the vast majority of established superhaplogroups. These are known to harbor different signature sequence motifs corresponding to their phylogenetic background that could have an effect on primer binding and, thus, could limit a broad application of this molecular genetic tool. The selected samples derived from various forensically relevant tissue sources and were DNA extracted using different methods. We evaluated sequence concordance and heteroplasmy detection and compared the findings to conventional Sanger sequencing as well as an orthogonal MPS platform. We discuss advantages and limitations of this approach with respect to forensic genetic workflow and analytical requirements.
- Published
- 2019
- Full Text
- View/download PDF
41. The maternal inheritance of Alto Paraná revealed by full mitogenome sequences
- Author
-
Elizeu Fagundes de Carvalho, Christina Strobl, Walther Parson, Nicole Huber, Leonor Gusmão, Carlos Vullo, Filipa Simão, Lisa Schnaller, Catarina Xavier, Patrícia Machado, Gabriela Huber, and Laura Catelli
- Subjects
Male ,0301 basic medicine ,Mitochondrial DNA ,Non-Mendelian inheritance ,Biology ,DNA, Mitochondrial ,Genome ,Haplogroup ,Pathology and Forensic Medicine ,03 medical and health sciences ,0302 clinical medicine ,parasitic diseases ,Ethnicity ,Genetics ,Humans ,030216 legal & forensic medicine ,1000 Genomes Project ,Phylogeny ,Haplotype ,Genetic Variation ,Sequence Analysis, DNA ,South America ,Maximum parsimony ,Genetics, Population ,030104 developmental biology ,Haplotypes ,Genetic distance ,Evolutionary biology ,Genome, Mitochondrial ,Female ,Maternal Inheritance - Abstract
Most studies on maternal lineages of South America populations are restricted to control region (CR) markers and, for some geographical regions, the number of studied samples does not adequately represent the existing diversity. This is the case of mitochondrial DNA (mtDNA) studies on Paraguay that are limited to two Native ethnic groups. To overcome this deficiency, we analysed the mitogenomes from 105 individuals living in Alto Parana, the second most populated department of the country. Using the Precision ID mtDNA Whole Genome Panel, the molecule was sequenced on Ion S5. The majority of the haplotypes belong to the Native American lineages A, B, C and D. Analyses of maximum parsimony using mitogenome data retrieved from publications and in The 1000 Genomes Project showed a high number of new native American subclades in Paraguay. Also, none of the haplotypes found in Alto Parana match the remaining South American samples, which include admixed populations from Colombia, Peru and Ecuador, and natives from Colombia and Ecuador. FST genetic distance analysis showed that the native genetic background of Alto Parana has an intermediate position between the Amazonian groups and the admixed populations from Peru and Ecuador, supporting the theory about the Amazonian origin of the Tupi-Guarani and, at the same time, showing the influence of other linguistic groups.
- Published
- 2019
- Full Text
- View/download PDF
42. 68Ga-Labeling: Laying the Foundation for an Anti-Radiolytic Formulation for NOTA-sdAb PET Tracers
- Author
-
Philippe Vanwolleghem, Julie Cousaert, Marleen Keyaerts, Catarina Xavier, Tony Lahoutte, Geert Raes, Henri Baudhuin, Vicky Caveliers, Supporting clinical sciences, Medical Imaging, Faculty of Medicine and Pharmacy, Department of Bio-engineering Sciences, Cellular and Molecular Immunology, Nuclear Medicine, and Clinical sciences
- Subjects
antioxidant ,Radical ,Size-exclusion chromatography ,Pharmaceutical Science ,radiolysis ,Article ,030218 nuclear medicine & medical imaging ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Pharmacy and materia medica ,gallium-68 ,Drug Discovery ,medicine ,NOTA-sdAb ,Gentisic acid ,Ethanol ,Polyvinylpyrrolidone ,Radiochemistry ,Ascorbic acid ,Thin-layer chromatography ,68Ga ,RS1-441 ,chemistry ,Radiology Nuclear Medicine and imaging ,030220 oncology & carcinogenesis ,Radiolysis ,Molecular Medicine ,Medicine ,radioprotectant ,medicine.drug - Abstract
During the preparation of [68Ga]Ga-NOTA-sdAb at high activity, degradation of the tracers was observed, impacting the radiochemical purity (RCP). Increasing starting activities in radiolabelings is often paired with increased degradation of the tracer due to the formation of free radical species, a process known as radiolysis. Radical scavengers and antioxidants can act as radioprotectant due to their fast interaction with formed radicals and can therefore reduce the degree of radiolysis. This study aims to optimize a formulation to prevent radiolysis during the labeling of NOTA derivatized single domain antibody (sdAbs) with 68Ga. Gentisic acid, ascorbic acid, ethanol and polyvinylpyrrolidone were tested individually or in combination to find an optimal mix able to prevent radiolysis without adversely influencing the radiochemical purity (RCP) or the functionality of the tracer. RCP and degree of radiolysis were assessed via thin layer chromatography and size exclusion chromatography for up to three hours after radiolabeling. Individually, the radioprotectants showed insufficient efficacy in reducing radiolysis when using high activities of 68Ga, while being limited in amount due to negative impact on radiolabeling of the tracer. A combination of 20% ethanol (VEtOH/VBuffer%) and 5 mg ascorbic acid proved successful in preventing radiolysis during labeling with starting activities up to 1–1.2 GBq of 68Ga, and is able to keep the tracer stable for up to at least 3 h after labeling at room temperature. The prevention of radiolysis by the combination of ethanol and ascorbic acid potentially allows radiolabeling compatibility of NOTA-sdAbs with all currently available 68Ge/68Ga generators. Additionally, a design is proposed to allow the incorporation of the radioprotectant in an ongoing diagnostic kit development for 68Ga labeling of NOTA-sdAbs.
- Published
- 2021
43. Cada um no seu quadrado: a identidade QRCode nos espaços de experimentação artística
- Author
-
Nogueira, Aurélio Antônio Mendes, primary, Gorini, Katia Correia, additional, Silva, Catarina Xavier Lopes da, additional, Santos, Melissa Anselmo dos, additional, Procaci, Laura Franco Gonçalves, additional, and Souza, Luiza Ferreira Motta de, additional
- Published
- 2021
- Full Text
- View/download PDF
44. Lyophilization of NOTA-sdAbs: First step towards a cold diagnostic kit for
- Author
-
Henri, Baudhuin, Pieter-Jan, Van Bockstal, Thomas, De Beer, Ilse, Vaneycken, Jessica, Bridoux, Geert, Raes, Vicky, Caveliers, Marleen, Keyaerts, Nick, Devoogdt, Tony, Lahoutte, and Catarina, Xavier
- Subjects
Gallium Radioisotopes ,Single-Domain Antibodies ,Ligands ,Peptide Fragments ,Excipients ,Heterocyclic Compounds, 1-Ring ,Mice ,Freeze Drying ,Drug Stability ,Cell Line, Tumor ,Isotope Labeling ,Positron-Emission Tomography ,Animals ,Humans ,Tissue Distribution ,Reagent Kits, Diagnostic ,Radiopharmaceuticals - Abstract
Lyophilization is commonly used in the production of pharmaceutical compounds to increase the stability of the Active Pharmaceutical Ingredient (API) by removing solvents. This study investigates the possibility to lyophilize an anti-HER2 and an anti-MMR single-domain antibody fragment (sdAb)-based precursor as a first step in the development of a diagnostic kit for PET imaging.NOTA-sdAb precursors have been lyophilized with the following formulation: 100 µg NOTA-sdAb in 0.1 M NaOAc (NaOAc), 5% (w/v%) mannitol-sucrose mix at a 2:1 ratio and 0.1 mg/mL polysorbate 80. During development of the formulation and drying cycle, factors such as cake appearance, glass transition temperature and residual moisture were analyzed to ensure qualitative and stable lyophilized samples. Stability studies of lyophilized precursor were conducted up to 18 months after storage at 2-8 °C by evaluating the precursor integrity, aggregation, functionality andThe lyophilized NOTA-anti-HER2 precursor shows consistent stability data in vitro for up to 12 months at 2-8 °C in three separate batches, with results indicating stability even for up to T18m. No aggregation, degradation or activity loss was observed. Radiochemical purity afterA formulation and specific freeze-drying cycle were successfully developed to lyophilize NOTA-sdAb precursors for long-term storage at 2-8 °C. In vivo data show no negative impact of the lyophilization process on the in vivo behavior or functionality of the lyophilized precursor. These results highlight the potential to develop a kit for the preparation of
- Published
- 2021
45. Corneal Subbasal Nerve Plexus Evaluation by
- Author
-
Diogo, Fernandes, Maria, Luís, Joana, Cardigos, Catarina, Xavier, Marta, Alves, Ana Luísa, Papoila, João Paulo, Cunha, and Joana Tavares, Ferreira
- Subjects
Adult ,Male ,Retinal Ganglion Cells ,Microscopy, Confocal ,Multiple Sclerosis ,Adolescent ,Visual Acuity ,Middle Aged ,Corneal Diseases ,Cornea ,Tonometry, Ocular ,Young Adult ,Cross-Sectional Studies ,Nerve Fibers ,ROC Curve ,Area Under Curve ,Humans ,Female ,Trigeminal Nerve ,Tomography, Optical Coherence ,Aged - Published
- 2021
46. Taboo Language in Context: An Exploratory Study of Taboo Language from the Point of View of Register
- Author
-
Catarina Xavier
- Subjects
050101 languages & linguistics ,Linguistics and Language ,uso marcado e não marcado ,05 social sciences ,P1-1091 ,050105 experimental psychology ,Language and Linguistics ,markedness ,systemic-functional linguistics ,linguística sistémico-funcional ,taboo language ,0501 psychology and cognitive sciences ,linguagem tabu ,Philology. Linguistics - Abstract
RESUMO Os falantes interagem através dos recursos linguísticos ao seu dispor para produzir significados ao nível da compreensão do mundo que os rodeia e dos restantes falantes (EGGINS, [1994] 2004, p. 11). O falante conhece, então, um código para cada situação comunicativa e adequa as suas seleções estilísticas ao contexto em que as produz. Neste enquadramento, este artigo exploratório investiga a linguagem tabu do ponto de vista das variáveis do contexto situacional, como propostas por Halliday (1978, [1985] 2014). Segue, por um lado, uma abordagem teórica onde propõe o cruzamento das variáveis do registro com os conceitos de uso marcado e não marcado (HYMES, 1974); e, por outro, aplica esta proposta num corpus escolhido para o efeito. Os resultados, de ordem quantitativa, demonstram o predomínio do uso não marcado da linguagem tabu no corpus. ABSTRACT Language users make use of several linguistic resources to make meanings regarding the world around them as well as others (EGGINS, [1994] 2004, p. 11). The user then recognizes a specific code for each communicative situation and selectively adapts his/her options to the particular context. Against this background, this article sets out to investigate taboo language from the standpoint of Register variables, proposed by Halliday (1978; [1985] 2014). On the one hand, we follow a theoretical approach by proposing an intersection between the register variables and the concept of markedness (HYMES, 1974). On the other hand, we make use of this proposal in a purpose-built corpus. Results show the predominance of the unmarked use of taboo in the corpus.
- Published
- 2021
47. O tabu no discurso cinemático: tradição, funções e reflexões
- Author
-
Catarina Xavier
- Subjects
Complementary and alternative medicine ,Pharmaceutical Science ,Pharmacology (medical) - Abstract
Although taboo has become an ever-increasing widespread linguistic resource within audiovisual contexts (Sapolsky et al. 2010; Bednarek 2019), and despite the importance sociolinguistic profiles hold in cinematic products, little research has been carried out on the topic.Thus, this study aims at examining the role taboo language plays in the movies. In order to do so, the presentation will combine a theoretical approach - geared towards the cinematic tradition of how taboo is used in the movies, the stereotyping of fictional characters through taboo and the relationship established between the use of taboo and the multimodal and ephemeral nature of cinematic products, with an applied approach – which presents the frequency of taboo words in six North-American movies as well as their functions. Based on the findings, this study suggests that taboo in cinema discourse can be disclosed in two different layers of functions: an intratextual function, concerning the role taboo plays within the narrative; and an extratextual function, related to the role taboo plays beyond the story, i.e. between the movie and the receivers. Further, more detailed, analysis showed that taboo is used intratextually, with an expletive, offensive, social or stylistic function, and, extratextually, with a mimetic, comic or ideological function; the frequency of each will help us characterize taboo in this audiovisual corpus.
- Published
- 2021
- Full Text
- View/download PDF
48. Development of the VISAGE enhanced tool and statistical models for epigenetic age estimation in blood, buccal cells and bones
- Author
-
Anna Woźniak, Ewa Kartasinska, Ewelina Pośpiech, Michał Boroń, Antonia Heidegger, Aleksandra Pisarek, Magdalena Spólnicka, Ana Freire-Aradas, Wojciech Branicki, Maria de la Puente, Catarina Xavier, Walther Parson, Harald Niederstätter, Rafał Płoski, Danuta Piniewska-Róg, Christopher Phillips, Marta Wojtas, Manfred Kayser, and Genetic Identification
- Subjects
Adult ,Male ,Aging ,epigenetic age prediction tool ,Adolescent ,Fatty Acid Elongases ,Buccal swab ,Kruppel-Like Transcription Factors ,Genomics ,Computational biology ,Biology ,Edar-Associated Death Domain Protein ,Bone and Bones ,bisulfite amplicon MPS ,age prediction in bones ,Amidohydrolases ,Epigenesis, Genetic ,03 medical and health sciences ,Young Adult ,0302 clinical medicine ,Multiplex polymerase chain reaction ,Humans ,Multiplex ,030216 legal & forensic medicine ,Epigenetics ,Child ,030304 developmental biology ,Aged ,Aged, 80 and over ,0303 health sciences ,EDARADD ,Models, Statistical ,DNA methylation ,Mouth Mucosa ,High-Throughput Nucleotide Sequencing ,Infant ,Cell Biology ,Sequence Analysis, DNA ,Middle Aged ,Biomarker (cell) ,Cyclic Nucleotide Phosphodiesterases, Type 4 ,Child, Preschool ,age prediction in blood and buccal cells ,CpG Islands ,Female ,Multiplex Polymerase Chain Reaction ,Blood Chemical Analysis ,Research Paper - Abstract
DNA methylation is known as a biomarker for age with applications in forensics. Here we describe the VISAGE (VISible Attributes through GEnomics) Consortium’s enhanced tool for epigenetic age estimation in somatic tissues. The tool is based on eight DNA methylation markers (44 CpGs), bisulfite multiplex PCR followed by sequencing on the MiSeq FGx platform, and three statistical prediction models for blood, buccal cells and bones. The model for blood is based on six CpGs from ELOVL2, MIR29B2CHG, KLF14, FHL2, TRIM59 and PDE4C, and predicts age with a mean absolute error (MAE) of 3.2 years, while the model for buccal cells includes five CpGs from PDE4C, MIR29B2CHG, ELOVL2, KLF14 and EDARADD and predicts age with MAE of 3.7 years, and the model for bones has six CpGs from ELOVL2, KLF14, PDE4C and ASPA and predicts age with MAE of 3.4 years. The VISAGE enhanced tool for age estimation in somatic tissues enables reliable collection of DNA methylation data from small amounts of DNA using a sensitive multiplex MPS assay that provides accurate estimation of age in blood, buccal swabs, and bones using the statistical model tailored to each tissue.
- Published
- 2021
49. Contributors
- Author
-
Silvio Aime, Ahmad Amirshaghaghi, Peggi M. Angel, Jan H. Ardenkjaer-Larsen, Raja Atreya, Sunny Awe, Cristian T. Badea, Freek J. Beekman, Siham Biade, Mark A. Borden, Ryan L. Brunsing, Prashant Chandrasekharan, Jae-Byum Chang, Fei Chen, John W. Chen, Xiaogyuan Chen, Zhen Cheng, Zhiliang Cheng, Emmanuel Cherin, Neal H. Clinthorne, Jonathan Cohen, Caylin Colson, Steven Conolly, Christopher H. Contag, Cathy S. Cutler, Paul A. Dayton, Nick Devoogdt, Olayinka Dina, Richard R. Drake, Stephen Dubsky, Frédéric Ducongé, Benjamin D. Fellows, F. Stuart Foster, Kevin P. Francis, Barry K.L. Fung, Sanjiv Sam Gambhir, Ruixuan Gao, Giovanni B. Giovenzana, Patrick Goodwill, Marlies C. Goorden, Dimitris Gorpas, Jan Grimm, Andrew N. Groll, Sally Hargus, Stefan Harmsen, Shuqing He, Daniel Hensley, Brian F. Hutton, Quincy Huynh, Andrei Iagaru, Lee Josephson, Silvia S. Jurisson, Paul Keselman, Moritz F. Kircher, Tushar Kokate, Justin Konkle, Joshua A. Korsen, Ahmet Krasniqi, Adebayo Laniyonu, Craig S. Levin, Michael R. Lewis, Jason S. Lewis, Guanshu Liu, Yajing Liu, Loren L. Looger, Kuan Lu, Yao Lu, Giovanni Lucignani, Scott K. Lyons, Theodosia Maina, Cristina Martelli, Alexander M. Matheson, Thorsten R. Mempel, Ling-Jian Meng, Farshad Moradi, Veronica L. Nagle, Markus F. Neurath, Fay Nicolson, Liming Nie, Vasilis Ntziachristos, Ryan Orendorff, Luisa Ottobrini, Yanli Ouyang, Maria G. Paez Segala, Grace Parraga, Mailyn Perez-Liva, Edwin C. Pratt, Jianghong Rao, Timo Rath, Elisenda Rodriguez, Eben L. Rosenthal, Brian D. Ross, Chinmoy Saayujya, Emine Ulku Saritas, Danielle A. Scott, Vipul R. Sheth, Connor Slagle, Ryo Tamura, Bertrand Tavitian, Zhi Wei Tay, Enzo Terreno, Mathew Thakur, Caleb Thompson, Jie Tian, Fabio Travagin, Andrew Tsourkas, Kathryn M. Tully, Shariq M. Usmani, Henry F. VanBrocklin, Stan van Keulen, Peter C.M. van Zijl, Rachel W. Walmer, Cuihua Wang, Joanna Wang, Lihong V. Wang, Catarina Xavier, Junjie Yao, Elaine Y. Yu, Xianchuang Zheng, Bo Zheng, and Xinyi Y. Zhou
- Published
- 2021
- Full Text
- View/download PDF
50. Newer Bioconjugation Methods
- Author
-
Nick Devoogdt, Ahmet Krasniqi, and Catarina Xavier
- Subjects
Bioconjugation ,Chemistry ,Moiety ,Nanotechnology ,Molecular imaging ,Linker ,Conjugate - Abstract
Clinical molecular imaging aims to detect particular biological processes, molecules, or cells in the body in a noninvasive manner. Frequently, it employs an imaging device that detects signals that are emitted by tracers. The tracer typically consists of a targeting vehicle that is connected, through a chosen linker chemistry to an imaging moiety. Frequently, the vehicle is of proteinaceous nature, such as a peptide, a small protein, or an antibody. This chapter provides an overview of newer methods to (bio-)conjugate imaging moieties such as chelated radionuclides, to protein vehicles. The focus will be both on the introduction of a conjugation handle on the proteins as well as on the chemistry to link it to the imaging moiety.
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.